Unión Europea - inglés - EMA (European Medicines Agency)

pfizer limited - difloxacin - antibacterials for systemic use, antiinfectives for systemic use - turkeys; dogs; cattle; chicken - chickens:for the treatment of chronic respiratory infections caused by sensitive strains of escherichia coli and mycoplasma gallisepticum.turkeys:for the treatment of chronic respiratory infections caused by sensitive strains of escherichia coli and mycoplasma gallisepticum.also for the treatment of infections caused by pasteurella multocida.dogs:for the treatment of acute uncomplicated urinary-tract infections caused by escherichia coli or staphylococcus spp. and superficial pyoderma caused by staphylococcus intermedius.cattle:for the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with pasteurella haemolytica, pasteurella multocida and / or mycoplasma spp.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ceva santé animale - colistin - oral solution - 2000000 international unit(s)/millilitre - colistin - cattle, chickens, pigs, sheep, turkeys - antibiotics

Reino Unido - inglés - VMD (Veterinary Medicines Directorate)

bimeda animal health limited - neomycin, sulfadiazine - oral suspension - antimicrobial - cattle

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

substipharm - nystatin - oral suspension - 100,000 international unit(s)/millilitre - antibiotics; nystatin

Australia - inglés - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - etravirine, quantity: 100 mg - tablet - excipient ingredients: hypromellose; croscarmellose sodium; magnesium stearate; lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica - etravirine, in combination with other antiretroviral agents is indicated for the treatment of hiv-1 infection in antiretroviral treatment-experienced adults who have evidence of viral replication and resistance to non-nucleoside transcriptase inhibitors and other antiretroviral agents.,this indication is based on 24-week analyses from 2 randomised, double-blind, placebo controlled trials of etravirine. both studies were conducted in clinically advanced, 3-class antiretroviral (nnrti, n(t)rti, pi) treatment-experienced adults (see section 5.1 pharmacodynamic properties ? clinical trials).,treatment history of patients and genotypic testing should be performed to guide the use of etravirine.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - etravirine, quantity: 200 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; hypromellose; magnesium stearate - etravirine, in combination with other antiretroviral agents is indicated for the treatment of hiv-1 infection in antiretroviral treatment-experienced adults who have evidence of viral replication and resistance to non-nucleoside transcriptase inhibitors and other antiretroviral agents.,this indication is based on 24-week analyses from 2 randomised, double-blind, placebo controlled trials of etravirine. both studies were conducted in clinically advanced, 3-class antiretroviral (nnrti, n(t)rti, pi) treatment-experienced adults (see section 5.1 pharmacodynamic properties ? clinical trials).,treatment history of patients and genotypic testing should be performed to guide the use of etravirine.

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chlorhexidine gluconate - mouthwash - 2mg/1ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

ecolab healthcare division - chlorhexidine gluconate - mouthwash - 2mg/1ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - chlorhexidine gluconate - mouthwash - 2mg/1ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - chlorhexidine gluconate - mouthwash - 2mg/1ml